ClinicalTrials.Veeva

Menu

Choroidal Change on OCTA in Eyes With High Myopia

N

Nanjing Medical University

Status

Not yet enrolling

Conditions

Choroid Disease
Myopia, Progressive

Treatments

Device: Optic coherence tomography angiography (OCTA)

Study type

Interventional

Funder types

Other

Identifiers

NCT04255524
OCTAPPA

Details and patient eligibility

About

Myopia is a global healthy concern, especially the high myopia and pathological myopia among Asian populations. However, its mechanism still remains largely unclear. Recent findings suggested choroidal changes might be related to the development of myopia. This study is to useOCT angiography (OCT-A) to investigate parapapillary choroidal microvasculature change in myopic eyes, and try to find the cause-and-effect relationship between choroidal change and the development of myopia.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Spherical equivalent measurement can be included in above 4 groups
  2. Willing to be followed up in the future 10 years

Exclusion criteria

  1. Deny to sign the patient consent, or deny to be followed
  2. Evidence of cardiac, or diabetic, or CNS disease.
  3. Clinically diagnosed with retinal or choroidal disease
  4. Glucoma
  5. Cataract or corneal disease that influence the quality of fundus OCTA image

Trial design

Primary purpose

Diagnostic

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

200 participants in 4 patient groups

Group 1/Control
Experimental group
Description:
Spherical equivalent: -2.00~+2.00 D
Treatment:
Device: Optic coherence tomography angiography (OCTA)
Group 1/Myopia
Experimental group
Description:
Spherical equivalent: -3.00~-6.00 D
Treatment:
Device: Optic coherence tomography angiography (OCTA)
Group 3/High
Experimental group
Description:
Spherical equivalent: -6.00~-10.00 D
Treatment:
Device: Optic coherence tomography angiography (OCTA)
Group 4/Super High
Experimental group
Description:
Spherical equivalent: \<-10.00
Treatment:
Device: Optic coherence tomography angiography (OCTA)

Trial contacts and locations

1

Loading...

Central trial contact

Zizong Hu, PhD, MD; Qinghuai Liu, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems